MeSH tree: N04
For patients with EGFR PACC-mutated non-small cell lung cancer (NSCLC), the targeted therapy firmonertinib achieved durable antitumor activity in a Phase Ib trial led by researchers at The University of Texas MD Anderson ...
1 hour ago
0
0
The historical gap in binge drinking, alcohol use disorder (AUD) and alcohol-related deaths between men and women has narrowed substantially over the last several decades in the United States, with binge drinking rates among ...
Oct 15, 2026
0
4
With artificial intelligence making deep inroads into health care, two doctors are urging physicians to embrace the technology but to remember that only humans can serve the best interests of individual patients.
Oct 14, 2026
0
5
Adding the targeted radioactive drug 177Lu-PNT2002 to stereotactic body radiation therapy, or SBRT, may help keep recurrent prostate cancer under control longer than SBRT alone, according to new research led by investigators ...
Oct 13, 2026
0
92
There's been a shift in how some medicines and therapeutic products are accessed and used.
Oct 12, 2026
0
4
Many of us use digital health tools every day, such as period trackers, fitness apps or online quizzes to check our mental health.
Oct 10, 2026
0
9
Treating individual metastatic tumors with highly focused radiation or surgery did not improve progression-free or overall survival for patients with oligometastatic breast cancer receiving first-line systemic therapy, according ...
Oct 8, 2026
0
6
When back or spine problems persist, figuring out where to go for care can be confusing. Should you see a neurosurgeon or an orthopedic surgeon? A neurologist or rehabilitation specialist? And if you see a spine surgeon, ...
Oct 8, 2026
1
72
People were about 19 percentage points less likely to recommend life-sustaining treatment for a seriously ill patient with dementia than for a patient without dementia, even when an advance directive requested life-sustaining ...
Oct 7, 2026
0
7
The Journal of Clinical Oncology has published secondary results from the ECOG-ACRIN Cancer Research Group's CompassHER2-pCR clinical trial (EA1181, NCT04266249). The findings help identify which early-stage HER2-positive ...
Oct 6, 2026
0
18
